舒尼替尼
生物医学工程
药物输送
角膜
纤维接头
体内
舒尼替尼
新生血管
材料科学
医学
血管生成
外科
纳米技术
眼科
病理
生物
癌症研究
生物技术
肾细胞癌
作者
Hyun Beom Song,KangJu Lee,Il Seo,Ji Yong Lee,Sang Mok Lee,Jin Hyoung Kim,Jeong Hun Kim,WonHyoung Ryu
标识
DOI:10.1016/j.jconrel.2015.04.041
摘要
It has been challenging for microneedles to deliver drugs effectively to thin tissues with little background support such as the cornea. Herein, we designed a microneedle pen system, a single microneedle with a spring-loaded microneedle applicator to provide impact insertion. To firmly attach solid microneedles with 140 μm in height at the end of macro-scale applicators, a transfer molding process was employed. The fabricated microneedle pens were then applied to mouse corneas. The microneedle pens successfully delivered rhodamine dye deep enough to reach the stromal layer of the cornea with small entry only about 1000 μm(2). When compared with syringes or 30 G needle tips, microneedle pens could achieve more localized and minimally invasive delivery without any chances of perforation. To investigate the efficacy of microneedle pens as a way of drug delivery, sunitinib malate proven to inhibit in vitro angiogenesis, was delivered to suture-induced angiogenesis model. When compared with delivery by a 30 G needle tip dipped with sunitinib malate, only delivery by microneedle pens could effectively inhibit corneal neovascularization in vivo. Microneedle pens could effectively deliver drugs to thin tissues without impairing merits of using microneedles: localized and minimally invasive delivery.
科研通智能强力驱动
Strongly Powered by AbleSci AI